13578_2020_444_MOESM3_ESM.jpg (398.3 kB)

Additional file 3 of Genome editing of CCR5 by AsCpf1 renders CD4+T cells resistance to HIV-1 infection

Download (398.3 kB)
figure
posted on 09.07.2020 by Zhepeng Liu, Jin Liang, Shuliang Chen, Kewu Wang, Xianhao Liu, Beibei Liu, Yang Xia, Mingxiong Guo, Xiaoshi Zhang, Guihong Sun, Geng Tian
Additional file 3: Figure S2. CCR5 and CXCR4 editing simultaneously by CRISPR/AsCpf1 protects the cells from CXCR4-tropic and CCR5-tropic HIV-1 infection. A, the target sequence of screened CRISPR/AsCpf1 usingCXCR4-sgRNAs. B, T7E1 confirmed editing efficacy of the screened CXCR4-sgRNAs. C, DNA sequencing of CXCR4 fragment after CRISPR/AsCpf1-CXCR4-#2 editing. D, the simultaneously ablation efficacy of CXCR4 and CCR5 after co-delivery of CRISPR/AsCpf1-CXCR4-#2 and CRISPR/AsCpf1-CCR5-#4 into TZM.bl cells. E, the CXCR4 and CCR5 modified TZM.bl cells or control were challenged with R5-tropic HIV-1YU-2 and X4-tropic HIV-1NL4-3 mix (1: 1) at MOI = 0.5. The data shown were the mean ± SD of three independent experiments. **P < 0.01; NS, not significant; Statistical analysis determined using unpaired t-test.

Funding

China National Special Research Program of Synthetic Biology Shenzhen`s Health and Family Planning Commission Program of Clinic Research

History

Exports